3 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Dong-Wook Kim: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder Lurasidone - Bipolar Disorder (BD) | Completed | Dong-Wook Kim | 155 | 2024-09-09 | 2026-10-05 | |
| Ropeginterferon for Treatment Free Remission Ropeginterferon - CML (Chronic Myelogenous Leukemia) | Phase 4 | Completed | Dong-Wook Kim | 65 | 2021-11-30 | 2025-08-22 |
| Genomics Study in CML Patients With Ponatinib Treatment Ponatinib - Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Completed | Dong-Wook Kim | 65 | 2020-09-01 | 2025-04-25 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Bipolar Disorder (1) · Overweight (1)
Lurasidone Hydrochloride (1) · ponatinib (1)
South Korea (3)